Advertisement

Topics

Latest AstraZeneca NewsRSS

06:47 EDT 29th June 2017 | BioPortfolio

Chi-Med and AstraZeneca Initiate SAVOIR, a Global Phase III Trial of Savolitinib in Papillary Renal Cell Carcinoma

Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) and AstraZeneca PLC (“AstraZeneca”) (LON/STO/NYSE: AZN) today announce that they have initiated a global pivotal Phase III, open-label, randomized multi-center registration study of the highly selective inhibitor of c-MET receptor tyrosine kinase, savolitinib, in c-MET-driven papillary ...

#jobs #lifescience AstraZeneca – Cambridge: TL/Associate Director – Early Product Development – Analytical

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: TL/Associate Director – Early Product Development – Analytical . Negotiable: AstraZeneca – Cambridge: Pharmaceutical Sciences is a department within Innovative Medicines and Early Development (IMED) … Continue reading U...

#jobs #lifescience AstraZeneca – Cambridge: Senior Scientist – In Vivo Sciences, UK

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Senior Scientist – In Vivo Sciences, UK . Negotiable: AstraZeneca – Cambridge: Position: Senior Scientist – In Vivo Sciences UKLocation: Babraham Research Campus, South Cambridge, … Continue reading → Cet article #jo...

#jobs #lifescience AstraZeneca – Cambridge: Scientist – In Vivo Sciences, UK

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Scientist – In Vivo Sciences, UK . Negotiable: AstraZeneca – Cambridge: Position: Scientist – In Vivo Sciences, UKLocation: Babraham Research Campus, South Cambridge, UKSalary: Competitive … Continue reading → Cet ar...

#jobs #lifescience AstraZeneca – Cambridge: Medical Scientist Early Clinical Development

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Medical Scientist Early Clinical Development . Negotiable: AstraZeneca – Cambridge: Placement: Gothenburg, Sweden. At AstraZeneca we believe in the potential of our people and you’ll … Continue reading → Cet article #jobs ...

Investors Take Options Cover Ahead of AstraZeneca PLC's Much-Anticipated Cancer Trial Data

  Life Sciences Jobs   ...

#jobs #lifescience AstraZeneca – Cambridge: Business Development Manager-Oncology

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Business Development Manager-Oncology . Negotiable: AstraZeneca – Cambridge: Position: Business Development Manager – OncologyLocation: Cambridge, UKSalary: Competitive plus excellent benefits As Business Development Manager, Oncology...

Osiris Names Former AstraZeneca PLC Exec as New CEO

  Life Sciences Jobs   ...

Cellular Dynamics Announces Agreement with AstraZeneca on Use of iPSC-derived Human Cells in Drug Discovery Research

MADISON, Wis., Jan. 3, 2013 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI) today announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery through the use of human induced pluripotent stem cell (iPSC) lines and tissue cells. iPSC technology, based on reprogramming adult cells from a simple blood sample or a skin biopsy to a pluripotent stem ...

#jobs #lifescience AstraZeneca – Cambridge: Associate Director – Early Product Development – Analytical

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Associate Director – Early Product Development – Analytical . Negotiable: AstraZeneca – Cambridge: Pharmaceutical Sciences is a department within Innovative Medicines and Early Development (IMED) … Continue reading →...

Sweden Launches Initiative to Establish Center for Cell and Gene Therapy Research

Sweden aims to establish a new Centre for Advanced Medical Products (CAMP) as part of a SEK 320 million ($36.6 million), 8-year Swedish governmental initiative to position the country as a leading biologics developer. Swedish regenerative medicine firm Xintela, has been appointed a partner in the 6-year project to establish the CAMP cell and gene therapy research centre, with SEK 48 million ($...

Sweden Launches Initiative to Establish Centre for Cell and Gene Therapy Research

Sweden aims to establish a new Centre for Advanced Medical Products (CAMP) as part of a SEK 320 million ($36.6 million), 8-year Swedish governmental initiative to position the country as a leading biologics developer. Swedish regenerative medicine firm Xintela, has been appointed a partner in the 6-year project to establish the CAMP cell and gene therapy research centre, with SEK 48 million ($...

#jobs #lifescience AstraZeneca – Cambridge: Business Development Manager – CVMD

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Business Development Manager – CVMD . Negotiable: AstraZeneca – Cambridge: Placement: Gothenburg, Sweden.At AstraZeneca, we work together across global boundaries to make an impact and … Continue reading → Cet article #job...

#jobs #lifescience AstraZeneca – Cambridge: Medical Communications Scientist (Regulatory Medical Writer)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Medical Communications Scientist (Regulatory Medical Writer) . Negotiable: AstraZeneca – Cambridge: Senior Medical Communications Scientist (Regulatory Medical Writer)Do you have strong experience in regulatory medical … Continue read...

#jobs #lifescience AstraZeneca – Cambridge: Senior Scientist – Mechanistic Biology & Profiling

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Senior Scientist – Mechanistic Biology & Profiling . Negotiable: AstraZeneca – Cambridge: Placement: Gothenburg, Sweden At AstraZeneca we win through science, it’s at the heart … Continue reading → Cet article #...

#jobs #lifescience AstraZeneca – Cambridge: Quality Control Analytical BioChemist, AstraZeneca Biologics

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Quality Control Analytical BioChemist, AstraZeneca Biologics . Negotiable: AstraZeneca – Cambridge: AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and … Continue readin...

#jobs #lifescience AstraZeneca – Cambridge: Senior Computational Chemist (Fragment-Based Lead Generation)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Senior Computational Chemist (Fragment-Based Lead Generation) . Negotiable: AstraZeneca – Cambridge: Position: Senior Computational Chemist (Fragment-Based Lead Generation)Location: Cambridge, UK.Salary: Very competitive with excellent bene...

#jobs #lifescience AstraZeneca – Cambridge: Associate Principal Scientist

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Associate Principal Scientist . Negotiable: AstraZeneca – Cambridge: Placement: Gothenburg, Sweden AstraZeneca is a global, innovation-driven pharmaceutical company focussing on the discovery, development and commercialization … Conti...

#jobs #lifescience AstraZeneca – Cambridge: Scientist/Senior Scientist – Drug Product Manufacture

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: AstraZeneca – Cambridge: Scientist/Senior Scientist – Drug Product Manufacture . Negotiable: AstraZeneca – Cambridge: Placement: Gothenburg, Sweden AstraZeneca (AZ) is a major international healthcare business engaged in the … Continue reading → C...

AstraZeneca to Acquire Omthera Pharmaceuticals Including NDA-Ready Novel Dyslipidemia Treatment to Complement Cardiovascular Portfolio

PRINCETON, N.J., May 28, 2013 /PRNewswire/ -- AstraZeneca today announced that it has entered into a definitive agreement to acquire Omthera Pharmaceuticals, a specialty pharmaceutical company based in Princeton, New Jersey, focused on the development and commercialization of new therapies for abnormal levels of lipids in the blood, referred to as dyslipidemia. Omthera's investigational produ...

Isis Pharmaceuticals Earns $10 Million Milestone Payment from AstraZeneca for ISIS-AR Rx to Treat Prostate Cancer

CARLSBAD, Calif., June 3, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that AstraZeneca has added a second development candidate, ISIS-ARRx, to its collaboration with Isis. Isis earned a $10 million milestone payment associated with this decision. ISIS-ARRx is an antisense drug designed to treat patients with prostate cancer by inhibiting the production of th...

Following Contract Dispute, GlaxoSmithKline Confirms Start Date for Former AstraZeneca PLC Exec

  Life Sciences Jobs   ...

How Upcoming Mystic Data Will be AstraZeneca PLC CEO's Biggest Test

  Life Sciences Jobs   ...

Former AstraZeneca PLC Exec Finally Gets a Start Date at GlaxoSmithKline

  Life Sciences Jobs   ...

AstraZeneca made Eliquis recalled in US says Bristol Myers-Squibb

Bristol Myers Squibb (B-MS) says the lot of Eliquis recalled in the US this week was made by AstraZeneca’s contract manufacturing business.

Quick Search
Advertisement
 

review and buy AstraZeneca market research data and corporate reports here